Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

BACKGROUND: Response to modern treatment strategies, which combine cytotoxic compounds with immune stimulatory agents and targeted treatment is highly variable among MCL patients. Thus, providing prognostic and predictive markers for risk adapted therapy is warranted and molecular information that c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Lokhande, Lavanya, Kuci Emruli, Venera, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Jerkeman, Mats, Ek, Sara
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720632/
https://ncbi.nlm.nih.gov/pubmed/33287742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07678-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы